Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Revenue

Axsome Therapeutics had revenue of $75.00M in the quarter ending March 31, 2024, a decrease of -20.70%. This brings the company's revenue in the last twelve months to $251.02M, up 73.58% year-over-year. In the year 2023, Axsome Therapeutics had annual revenue of $270.60M with 440.80% growth.

• Revenue (ttm): $251.02M
• Revenue Growth: +73.58%
• P/S Ratio: 16.37
• Revenue / Employee: $460,593
• Employees: 545
• Market Cap: 4.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	270.60M	220.56M	440.80%
Dec 31, 2022	50.04M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.